Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malaria

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 42 articles:
HTML format



Single Articles


    December 2021
  1. VAN DER PLUIJM RW, Phyo AP, Lek D, White NJ, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution - Authors' reply.
    Lancet. 2021;396:1976-1977.
    PubMed    


  2. WANG J, Xu C, Wong YK, Ma N, et al
    Triple artemisinin-based combination therapies for malaria: proceed with caution.
    Lancet. 2021;396:1976.
    PubMed    


    October 2021
  3. SAMARASEKERA U
    Cautious optimism for malaria vaccine roll-out.
    Lancet. 2021;398:1394.
    PubMed    


  4. THE LANCET
    Malaria vaccine approval: a step change for global health.
    Lancet. 2021;398:1381.
    PubMed    


    May 2021
  5. MOORTHY V, Binka F
    R21/Matrix-M: a second malaria vaccine?
    Lancet. 2021 May 5. pii: S0140-6736(21)01065.
    PubMed    


  6. DATOO MS, Natama MH, Some A, Traore O, et al
    Efficacy of a low-dose candidate malaria vaccine, R21 in adjuvant Matrix-M, with seasonal administration to children in Burkina Faso: a randomised controlled trial.
    Lancet. 2021 May 5. pii: S0140-6736(21)00943.
    PubMed     Abstract available


    April 2021
  7. LANE R
    Faith Osier: inspirational immunologist.
    Lancet. 2021;397:1533.
    PubMed    


    March 2021
  8. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    PubMed    


    February 2021
  9. BATH D, Cook J, Govere J, Mathebula P, et al
    Effectiveness and cost-effectiveness of reactive, targeted indoor residual spraying for malaria control in low-transmission settings: a cluster-randomised, non-inferiority trial in South Africa.
    Lancet. 2021;397:816-827.
    PubMed     Abstract available


  10. STERNBERG ED, Cook J, Alou LPA, Assi SB, et al
    Impact and cost-effectiveness of a lethal house lure against malaria transmission in central Cote d'Ivoire: a two-arm, cluster-randomised controlled trial.
    Lancet. 2021;397:805-815.
    PubMed     Abstract available


  11. HSIANG MS, Mumbengegwi D, Chimumbwa J
    Mini-outbreak response for malaria using indoor residual spraying.
    Lancet. 2021;397:771-773.
    PubMed    


  12. CHANDA E
    Averting malaria transmission with lethal house lure intervention.
    Lancet. 2021;397:769-771.
    PubMed    


    December 2020

  13. Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study.
    Lancet. 2020;396:1829-1840.
    PubMed     Abstract available


  14. ASHLEY EA, Yeka A
    Seasonal malaria chemoprevention: closing the know-do gap.
    Lancet. 2020;396:1778-1779.
    PubMed    


    November 2020
  15. MAKONI M
    Violence leads to health emergencies in Mozambique.
    Lancet. 2020;396:1621.
    PubMed    


    June 2020
  16. PRICE RN, Taylor WRJ, Thriemer K, White NJ, et al
    Primaquine for Plasmodium vivax malaria treatment - Authors' reply.
    Lancet. 2020;395:1972.
    PubMed    


  17. KARUNAJEEWA H, James R
    Primaquine for Plasmodium vivax malaria treatment.
    Lancet. 2020;395:1971-1972.
    PubMed    


    April 2020
  18. CHEN I, Dondorp A, Gosling R, Harvard K, et al
    Malaria eradication - Authors' reply.
    Lancet. 2020;395:e73.
    PubMed    


  19. ECKL J
    Malaria eradication.
    Lancet. 2020;395:e72.
    PubMed    


  20. MOLYNEUX D
    Malaria eradication.
    Lancet. 2020;395:e71.
    PubMed    


  21. KENNEDY J, McCoy D
    Malaria eradication.
    Lancet. 2020;395:e70.
    PubMed    


  22. WANG J, Xu C, Wong YK, Liao FL, et al
    Malaria eradication.
    Lancet. 2020;395:e69.
    PubMed    


  23. MULLER O, Lu G, Jahn A, Razum O, et al
    Malaria eradication.
    Lancet. 2020;395:e68.
    PubMed    


  24. ANTIPORTA DA, Rosas-Aguirre A, Chang J, Llanos-Cuentas A, et al
    Malaria eradication.
    Lancet. 2020;395:e67.
    PubMed    


  25. HSIANG MS, Ntuku H, Roberts KW, Dufour MK, et al
    Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
    Lancet. 2020;395:1361-1373.
    PubMed     Abstract available


  26. KEATING C
    The history of the RTS,S/AS01 malaria vaccine trial.
    Lancet. 2020;395:1336-1337.
    PubMed    


  27. HETZEL MW, Chitnis N
    Reducing malaria transmission with reactive focal interventions.
    Lancet. 2020;395:1317-1319.
    PubMed    



  28. Health sector spending and spending on HIV/AIDS, tuberculosis, and malaria, and development assistance for health: progress towards Sustainable Development Goal 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30608.
    PubMed     Abstract available


  29. SUNDEWALL J, Forsberg BC
    Understanding health spending for SDG 3.
    Lancet. 2020 Apr 23. pii: S0140-6736(20)30963.
    PubMed    


  30. STAEDKE SG, Gonahasa S, Dorsey G, Kamya MR, et al
    Effect of long-lasting insecticidal nets with and without piperonyl butoxide on malaria indicators in Uganda (LLINEUP): a pragmatic, cluster-randomised trial embedded in a national LLIN distribution campaign.
    Lancet. 2020;395:1292-1303.
    PubMed     Abstract available


  31. BAJUNIRWE F
    Pyrethroid resistance in sub-Saharan Africa.
    Lancet. 2020;395:1236-1237.
    PubMed    


  32. KILLEEN GF
    Control of malaria vectors and management of insecticide resistance through universal coverage with next-generation insecticide-treated nets.
    Lancet. 2020 Apr 15. pii: S0140-6736(20)30745.
    PubMed    


    March 2020
  33. WANG J, Xu C, Wong YK, He Y, et al
    Preparedness is essential for malaria-endemic regions during the COVID-19 pandemic.
    Lancet. 2020 Mar 16. pii: S0140-6736(20)30561.
    PubMed    


  34. VAN DER PLUIJM RW, Tripura R, Hoglund RM, Pyae Phyo A, et al
    Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial.
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30552.
    PubMed     Abstract available


  35. ROSENTHAL PJ
    Are three drugs for malaria better than two?
    Lancet. 2020 Mar 11. pii: S0140-6736(20)30560.
    PubMed    


  36. MCGREADY R, Nosten F, Barnes KI, Mokuolu O, et al
    Why is WHO failing women with falciparum malaria in the first trimester of pregnancy?
    Lancet. 2020;395:779.
    PubMed    


    January 2020
  37. FOWKES FJI, Davidson E, Moore KA, McGready R, et al
    The invisible burden of malaria-attributable stillbirths.
    Lancet. 2020;395:268.
    PubMed    


  38. GETHING P, Hay S, Weiss D
    The invisible burden of malaria-attributable stillbirths - Authors' reply.
    Lancet. 2020;395:268-269.
    PubMed    


    October 2019
  39. TCHIOMBIANO S, Delfraissy JF, Dabis F
    The Global Fund's Sixth Replenishment Conference: a challenge for France, a challenge for global health.
    Lancet. 2019;394:1214-1215.
    PubMed    


    September 2019
  40. FOY BD, Rao S, Parikh S, Slater HC, et al
    Analysis of the RIMDAMAL trial - Authors' reply.
    Lancet. 2019;394:1006-1007.
    PubMed    


  41. COLEBUNDERS R, Kugler M, Fodjo JNS
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1006.
    PubMed    


  42. BRADLEY J, Moulton LH, Hayes R
    Analysis of the RIMDAMAL trial.
    Lancet. 2019;394:1005-1006.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Malaria is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: